DeMON
  • Home
  • Meet the Team
  • Research
  • Research Publications
  • Publication pages
    • All publications
  • News
  • Contact

Welcome!

In the DeMON Lab, we develop computational models that integrate neuroimaging and multi-omics data to understand disease progression and biological heterogeneity in neurodegenerative diseases.

Our work combines statistical learning, disease progression modelling, and molecular profiling to identify meaningful disease subtypes and biological changes associated with neurodegeneration.

Find us here LinkedIn GitHub X Google Scholar

About the Lab

In the DeMON Lab, we investigate how neurodegenerative diseases develop and progress over time. Our research focuses primarily on Alzheimer’s disease but also other neurodegenerative disorders, with the goal of identifying biological changes at any stage of the disease, even those that precede clinical symptoms, and understanding why individuals experience disease differently.

To address these questions, we integrate large-scale neuroimaging, molecular, genetic, and clinical datasets. By combining statistical learning, disease progression modelling, and multi-omics approaches, we develop computational methods that model disease progression, reveal patterns of heterogeneity in these diseases, identify biologically meaningful subtypes, and improve our understanding of disease mechanisms.

Our research group is also privileged with a large network of collaborators that help push forward the lab’s research goals by providing both expert domain knowledge and rare datasets.

We are committed to open and reproducible science, FAIR data principles, and the development of methods and resources that benefit the wider research community.

Latest from the Lab

Study overview: UK Biobank cohort and data, three organ-level proteomic metrics, and their associations with brain structure and disease
Figure from this paper (CC BY-NC 4.0).
Latest publication
Romina Zendehdel et al., bioRxiv, Nov 10, 2026

Beyond organ age gaps: comparing plasma proteomic metrics of organ biology in relation to brain structure and neurodegenerative disease

Neurodegenerative diseases mainly affect the brain, but biological changes throughout the body may matter too. Using plasma proteomics from over 50,000 UK Biobank participants, we compared three organ-level proteomic metrics (organ age gap, PC1 and PLS1) in relation to brain structure and disease risk. Aging of specific organs was linked to thinning of specific brain regions. Organ age gaps predicted incident neurological disease best of the three, but added only modestly to prediction models.

Read the paper All publications
Jacob Vogel speaking at the podium at the award ceremony
News
May 2026

Jacob Vogel receives the Young Researcher Prize 2026

Our PI Jacob Vogel was awarded the Young Researcher Prize 2026 by the Fondation Recherche Alzheimer, at the award ceremony held at the AD/PD meeting in Copenhagen. Congratulations, Jake!

All news

Research Network